Skip to NavigationSkip to content

News

Sanofi and Regeneron’s Praluent (alirocumab) has been awarded approval by the European Commission, it has emerged, as a therapy to reduce...
The FDA has granted OxyContin drugmaker Purdue Pharma, fast track designation for opioid overdose antidote nalmefene hydrochloride (HCl) injection...
Merck KGaA and AI firm Iktos have entered into a partnership, the pair have announced, to leverage the latter’s generative modelling AI technology...
The European Commission (EC) has approved Roche’s haemophilia treatment Hemlibra (emicizumab).
MSD’s anti-PD-L1 therapy Keytruda (pembrolizumab) has been awarded marketing authorisation in Europe for the first-line treatment of adult patients...
- 23andMe to offer genetic reports on diabetes - Dutch pharmacists to circumvent Novartis cancer drug market exclusivity - New class of drugs offer...
Ian Read has seen his total compensation cut from a sum of $27.9 million in 2018 to $19.5 million this year.
Roche has announced along with its partner Chugai that Hemlibra (emicizumab) has secured approval from the European Commission as a preventative...
Celgene’s Abraxane, in combination gemcitabine, has failed to meet its primary endpoint in a pivotal Phase 3 trial of patients with pancreatic cancer.
A new class of cholesterol lowering drugs may help patients who are unable to take statins, according to a study published in the New England...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches